Bisphosphonates and osteonecrosis of the jaw

Australian Family Physician

Volumn 35, Issue 10, 2006, Pages 801-803

  Sambrook, Philip ^a   Olver, Ian ^a   Goss, Alastair ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ARTICLE; BONE NECROSIS; BONE TUMOR; CHEMICALLY INDUCED DISORDER; HUMAN; JAW DISEASE; OSTEOPOROSIS; PAGET BONE DISEASE; PRACTICE GUIDELINE;

BONE NEOPLASMS; DIPHOSPHONATES; HUMANS; JAW DISEASES; OSTEITIS DEFORMANS; OSTEONECROSIS; OSTEOPOROSIS; PRACTICE GUIDELINES;

EID: 33845942551     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Available at www.medicareaustralia.gov.au/cgi-bin/ broker.exe.
2. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004;62:527-34.
3. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61:1115-7.
4. Migliorati CA. Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 2003;21:4253-4.
5. Carter GD, Goss AN. Letter to the editor. Bisphosphonates and avascular necrosis of the jaws. Aust Dent J 2003;48:268.
6. Carter GD, Goss AN. Bisphosphonates and avascular necrosis of the jaws. Australian Prescriber 2004;27(2 Suppl):32-3.
7. Available at www.fredcoutts.com/zometa/zometanews.htm.
8. Purcell PM, Boyd IW. Bisphosphonates and osteonecrosis of the jaw. Med J Aust 2005;182:417-8.
9. Bisphosphonates and osteonecrosis of the jaws. Adverse Drug Reactions Bulletin 2006;25:4.
10. Expert Panel Recommendations for the prevention, diagnosis and treatment of osteonecrosis of the jaws. June 2004 (Novartis). Available at www.ada.org/prof/resources/topics/topics_osteonecrosis_whitepaper.pdf.
11. Dental health. Taking care of yourself while living with cancer. May 2005 (Novartis). Available at www.zometa. com/pdfs/ZOM_Dental_UK.pdf.
12. Carter GD, Doecke C. Goss AN. Bisphosphonates and avascular necrosis of the jaw: a possible association. Med J Aust 2005;182:413-5.
13. Cheng A, Mavrokokki A, Carter G, et al. The dental implications of bisphosphonates and bone disease. Aust Dent J 2005;(Suppl 2):50.
14. Warnke PH, Springer IN, Russo PAJ, et al. Innate immunity in human bone. Bone 2006;38:400-8.
15. Hoff AO, Toth, B, Altunag K, et al. Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy. J Bone Miner Res 2005;(20 Suppl)1:1218.
16. Mavrokokki A, Cheng A, Stein B, Goss AN. The nature and incidence of bisphosphonate associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 2006; in press.
17. Felsenberg D, Hoffmeister B, Michael Amling M. Bisphosphonattherapie assoziierte. Kiefernekrosen Deutsches Arzteblatt 2006; in press.
18. Ruggiero S, Gralow J, Marx RE, et al. Practical guidelines for the prevention, diagnosis and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract 2006;1:7-14.
19. Migliorati C, Casiglia J, Epstein J, Jacobsen P, Siegal MA, Woo S-B. Managing the care of patients with bisphosphonate associated osteonecrosis. An American Academy of Oral Medicine position paper. JAOA 2005;136:1658-68.
20. Woo SB, Hellstein, JW, Kalmer JR. Systematic review. Bisphosphonates and osteonecrosis of the jaw. Ann Int Med 2006;144:753-61.
21. Editorial. Osteonecrosis of the jaw, more research needed. J Bone Miner Res 2006; in press.